P , .0001, respectively). There was no statistical difference between mortality risks through any combination of s-albumin and BMI values (P 5 .54).
Conclusion: Malnutrition and reduced s-albumin levels were found to be independent predictors of mortality, whereas being overweight and obese did not show protective effects. Crown Copyright Ó 2012 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. All rights reserved. P ROTEIN ENERGY WASTING and poor nutritional status are common in patients with end-stage kidney disease (ESKD) on maintenance dialysis. [1] [2] [3] These are strong predictors of mortality and morbidity and are associated with poor quality of life. 4, 5 Factors affecting nutrition in uremic patients include (1) disturbance of energy, protein, and nutrients metabolism, 6 (2) metabolic acidosis, 7 (3) anorexia, taste change, and poor appetite that may lead to suboptimal dietary intake, [8] [9] [10] (4) dialysis procedures per se, 4 such as bioincompatibility, inadequate dialysis, protein and other nutrient losses, and peritoneal dialysis (PD) dialysate-induced glucose loading and sense of fullness, 11 (5) hormonal derangement, 12 (6) comorbidities, such as cardiovascular disease and diabetes mellitus, (7) infection and intercurrent illnesses, (8) chronic inflammation, 2 (9) altered muscle metabolism 13 and physical inactivity, 14 (10) loss of residual renal function, 15 (11) psychosocial issues 16 and poor food management skill, and (12) conditions associated with various stages of lifecycle that require additional nutritional attention, such as menopause, aging-related sarcopenia, and poor dentition. Many of these nutrition abnormalities emerge during the progressive decline of renal function before dialysis is required. 8, 17 In the dialysis population, nutritional factors found to predict mortality risk are anthropometric measures, such as low weight-to-height ratio, 18 low body mass index (BMI), and unintentional weight loss 19 ; abnormal laboratory results, such as high level of C-reactive protein (CRP) 20 and low levels of lymphocytes, parathyroid hormone, serum albumin, prealbumin, and hemoglobin 19, [21] [22] [23] [24] [25] ; poor appetite, 26 muscle wasting, 27 suboptimal intakes of energy and protein, 9 low exercise capacity, 14 and poor functional capacity measured by hand grip strength 27 ; and malnutrition score using subjective global assessment (SGA). 28 Many of these abnormalities present at the start of dialysis and predicted poor outcomes. 4, 27, 28 However, there has been much debate on the prognostic significance of s-albumin-CRP, 28 ,29 BMI, [30] [31] [32] [33] and timing of initiation of dialysis. 34, 35 It is necessary to understand the relationships between mortality and these modifiable factors so that predialysis intervention can be considered to improve outcomes. The aims of the present study were (1) to describe the demographic, clinical, and nutritional characteristics in a cohort of ESKD patients who commenced on planned dialysis program in our unit, (2) to examine the associations between these factors and mortality, and (3) to examine the combined effects of nutritional factors on mortality risk, as these methods were seldom investigated in the previous studies.
Patients and Methods
This was a retrospective clinical cohort study involving all incident hemodialysis (HD) and PD patients at the renal unit of The George Hospital, Sydney, Australia, between August 1, 2000 and July 31, 2005. All patients were followed until death, or they were censored at transplant or at the end of the observational period on July 31, 2010. This means all patients completed at least 5 years of follow-up during the 10-year study period. Inclusion criteria were ESKD patients who were older than 18 years and who commenced a planned dialysis program after gradual decline of renal function without history of acute kidney injury (AKI) and renal replacement therapy (RRT). Initiation of dialysis was recommended by the patients' primary nephrologists based on clinical judgments (e.g., when glomerular filtration rate [GFR] was ,7 mL/minutes/1.73 m 2 or indication of uncontrolled uremic symptoms such as volume overload). Exclusion criteria were patients in whom dialysis was initiated because of AKI with or without recovering renal function, previous history of RRT, planned early discontinuation of dialysis program from our unit (e.g., living donor transplantation or transfer This article has an online CPE activity available at www.kidney.org/professionals/CRN/ceuMain.cfm
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to another unit), and incomplete assessment by the dietitian within 4 weeks of dialysis initiation.
Clinical and demographic data extracted from the hospital clinical notes and the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) included age; gender; race; smoking history (never smoked or combined ex-and current smokers); late referral to nephrologists, defined as ,3 months under specialist care before starting dialysis; and comorbidities, such as coronary artery disease (CAD), cerebral vascular disease (CVD), diabetes mellitus (DM), chronic lung disease (CLD), and peripheral vascular disease (PVD). ANZDATA classified the presence of comorbidity as ''yes,'' ''suspected,'' or ''no''; data of ''yes'' and ''suspected'' were combined as ''presence of '' for analysis in this study. Mortality and cause of death were also extracted.
In line with the clinical guidelines, 36 which are based on the latest best evidence and expert opinion, if a high level of evidence did not exist or was inconclusive, all patients were assessed by the renal unit dietitians, including the author M.C., as part of the routine care. Anthropometric measures included for analysis were height (m), edema-free body weight (kg), BMI 5 weight O height 2 (m/kg 2 ), and weight history (in particular if any unintentional weight loss occurred in the previous 6 months for SGA rating). The previous routine blood results before the first dialysis session were extracted from clinical notes. These included s-albumin (reference range, 3.3 to 5.3 g/dL) and serum creatinine results to calculate GFR using the Cockcroft-Gault equation. The survival risk between the early and late starting groups was compared using the Initiating Dialysis Early and Late (IDEAL) trial intended cutoff of $7 and ,7 mL/minutes/1.73 m 2 as early and late initiation, respectively 37 ; further analyses were performed at cutoffs of 8, 9, and 10 mL/minutes/1.73 m 2 . To eliminate the negative effect of acute-phase response of s-albumin due to the insertion of PD catheter, the most recent s-albumin readings before the procedures were used. Other assessment performed by the renal dietitian(s) was SGA, 38 which categorizes patients as A 5 well nourished, B 5 mild-moderately malnourished, and C 5 severely malnourished, based on the patient's medical history and physical examination. Urea kinetic studies were routinely performed for all patients throughout the study period to meet the optimal national dialysis targets. 39 The clinical practice guidelines 36 All tests were performed using the statistical software SPSS version 18 (SPSS Inc, Chicago, IL). Continuous variables were expressed as mean 6 standard deviation for normally distributed data and as medians with interquartile ranges for non-normally distributed data. For continuous variables, comparisons between groups were performed using unpaired sample t test for normally distributed variables or the Mann-Whitney test for non-normally distributed variables, whereas categorical variables were compared using the c 2 test. Survival analysis was performed using the Kaplan-Meier method (univariate analysis), and Cox proportional hazard analysis (multivariate analysis) was used to assess the independent association between baseline parameters and mortality. Effect of age (.65 years), GFR (,7 mL/minutes/1.73 m 2 ), s-albumin (,3.3 g/dL), and BMI ($26 and $30 kg/m 2 ) as continuous and categorical variables were also examined. P ,.05 was considered to be statistically significant.
The study was approved by the ethics committee of the South Eastern Sydney and Illawarra Area Health Service, NSW, Australia.
Results
Dialysis was initiated in 330 patients in the defined period. Of these, 167 patients (50.6%) met
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the inclusion criteria. One hundred sixty-three patients (49.4%) were excluded from analysis because of AKI with or without recovering renal function (32.8%), previous history of RRT (2.1%), planned early discontinuation of dialysis program from our unit (10.3%), and other causes (e.g., ,18 years of age, incomplete dietitian assessment within 4 weeks of enrollment, or missing data; 4.2%). The mean age (6standard deviation) of the studied subjects was 65.3 6 13.6 years (male, 61.7%). Of these patients, 57.5% were on HD and the rest were on PD at day 90 after enrollment; 64 patients (38.3%) switched dialysis modality during the study period. Similar survival rates were reported in the literature for both modalities 28 ,42 even after switching from one to the other. 43 As we found similar results by the Kaplan-Meier analysis (P 5 .89), all HD and PD data were combined for analysis. Twenty-eight patients (16.8%) received a kidney transplant after entry to the study.
The baseline demographic, clinical, and nutritional characteristics of the studied patients at the initiation of dialysis are listed in Table 1 .
Late referral (,90 days) to the nephrologists was noted in 8.5% of patients, and dialysis was commenced with a mean GFR of 8.0 6 2.7 mL/minutes/1.73 m 2 . Apart from body weight and serum creatinine, there was no statistical difference between male and female patients for all other demographic, clinical, and nutritional parameters. In all, 111 patients (66.6%) died, including 2 of the transplanted patients, by the end of the observation period. Three patients were transferred to other hospitals, but their survival data were obtained from the ANZDATA for analysis. Median follow-up time was 53.0 (interquartile range, 23 to 83) months, with 96.5 (76.3 to 108.8) versus 29 (17.0 to 53.0) months for survivors and nonsurvivors, respectively. The causes of ESKD and death are listed in Table 2 . The main cause of ESKD was diabetic nephropathy (24%). The most common cause of death was withdrawal of dialysis due to refusal and quality of life measures (21.6%).
Among the patients studied, dialysis was initiated early in 37.2% ($7 mL/minutes/1.73 m 2 ) and late in 62.8% (,7 mL/minutes/1.73 m 2 ), 2), P , .0001; 9 mL/minutes/1.73 m 2 (11.1 6 1.5 vs. 6.6 6 2.1), P , .0001; or 10 mL/minutes/ 1.73 m 2 (12.0 6 1.6 vs. 6.9 6 2.1), P , .0001. Our data indicated that GFR levels at which dialysis started were not found to have any association with mortality risk.
Among the lifestyle and comorbidity parameters, PVD was independently associated with higher mortality risk (P ,.0001), whereas the significance of CAD disappeared in the adjusted analyses (P 5.10). Smoking and all other comorbidities did not show any statistically significant effect on mortality risks (Table 3) .
Fifty-eight percent of patients had s-albumin levels ,3.3 g/dL (reference range, 3.3 to 5.3 g/ dL). The low-s-albumin group, when compared Within the cohort, 47.9%, 41.9%, and 10.2% of patients were rated as well nourished (SGA 5 A), mildly to moderately malnourished (SGA 5 B), and severely malnourished (SGA 5 C), respectively. Kaplan-Meier analysis indicated a significant difference in the mortality risk between the 3 groups (P , .0001). After adjusting for all other variables using the Cox proportional hazard model, the survival curves of SGA B and C merged, and the combined malnourished group (SGA 5 B and C, 52.1%) showed significantly higher mortality risk compared with the wellnourished group (SGA 5 A) (adjusted hazard ratio [HR], 1.74; 95% confidence interval [CI], 1.11 to 2.72; P 5.02; Table 3 and Fig. 1) . Therefore, malnutrition was found independently associated with mortality. It is worth noting that the wellnourished group had significantly more diabetic patients than the malnourished group (41.4% vs. 
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kg/m 2 group (referent) (Fig. 2) When the combined effects of SGA and s-albumin were examined (Fig. 3) , no statistical difference in mortality risk was observed between the SGA 5 A 1 s-albumin $3.3 g/dL or SGA 5 A 1 s-albumin ,3.3 g/dL group (HR, 1.25; 95% CI, 0.65 to 2.45; P 5.51), although the latter had significantly lower level of s-albumin (3.5 6 0.2 vs. 2.9 6 0.4 g/dL, P , .0001). In comparison with SGA 5 A 1 s-albumin $3.3 g/dL group (referent), the SGA 5 B and C 1 s-albumin $3.3 g/dL group was associated with a 2-fold (HR, 2.06; 95% CI, 1.06 to 4.00; P 5.03) increase in mortality risk despite no difference in s-albumin levels (3.5 6 0.2 vs. 3.5 6 0.3 g/dL, P , .90). Among the SGA B and C groups with s-albumin $3.3 g/dL or ,3.3 g/dL, no statistical difference in mortality risk (P 5 .26) was observed despite the statistical difference in s-albumin levels (3.5 6 0.3 vs. 2.8 6 0.3 g/dL, P # .0001). An almost 3-fold increase in mortality risk was observed for SGA 5 B and C 1 s-albumin ,3.3 g/dL group compared with the SGA 5 A 1 s-albumin $3.3 g/dL group (HR, 2.86; 95% CI, 1.66 to 4.94; P # .0001).
There was no statistical difference in mortality risk among any combinations of s-albumin (, or $3.3 g/dL) and BMI (, or $26 kg/m 2 ) categories (P 5.53).
In summary, after adjusting for all variables, including age, gender, dialysis modality, GFR level at which dialysis started, s-albumin levels, BMI, malnutrition score (SGA B and C), smoking, and all co-morbidities, advanced age (.65 years; P ,.0001), presence of PVD (P ,.0001), reduced s-albumin levels (P 5.01), and malnutrition scored as SGA B and C (P 5.02) independently predicted mortality. Combined effects of SGA A with BMI ,26 kg/m 2 or s-albumin $3.3 g/dL were associated with better survival.
Discussion
Our cohort represented a relatively homogenous group of ESKD patients who showed an uneventful but gradual decline of renal function with no history of AKI and RRT. We observed a high prevalence (52.1%) of malnutrition (SGA B and C) at the start of dialysis. Malnutrition, together with advanced age, reduced s-albumin levels, and presence of PVD independently predicted mortality during the 10-year study period. Gender, dialysis modalities, GFR level at which dialysis was commenced, BMI, positive smoking history, and comorbidities other than PVD did not show any statistically significant effect on mortality risk.
In search of the optimal timing for when dialysis should start, the IDEAL trial 37 compared the mortality between early-(10 to 14 mL/minutes/1.73 m 2 ) and late-start (5 to 7 mL/minutes/1.73 m 2 ) groups. The mean GFR of the early-and late-starting group resulted at 12.0 mL/minutes/1.73 m 2 and 9.8 mL/ minutes/1.73 m 2 , respectively, in the study because of various clinical and social decisions. No statistical difference in survival or clinical outcomes was observed between the early-or late-starting groups. Our cohort study, which included patients with a wider range of clinical implications, also showed no difference in mortality risk when the analyses Figure 3 . Adjusted survival curves of the combined effects of SGA and s-albumin evaluated at the start of dialysis. Note: Group 1 versus 2 (P 5 .51), group 1 versus 3 (P 5 .03), group 1 versus 4 (P , .0001), group 2 versus 3 (P 5 .16), group 2 versus 4 (P 5 .004), group 3 versus 4 (P 5 .26). SGA, subjective global assessment: A 5 well nourished, B&C 5 malnourished; Alb, s-albumin in g/dL.
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were performed at the GFR cutoff of 7 mL/minutes/1.73 m 2 , as initially planned in the IDEAL trial, or at the cutoff of 8, 9, and 10 mL/minutes/1.73 m 2 .
Our results supported the recommendations of the IDEAL trial and other observational studies 35, 44 that with careful clinical management of ESKD, including nutritional inputs, dialysis can be started at lower levels of GFR (,7 mL/minutes/1.73 m 2 ). 34, 45 In agreement with the literature, we found no significant difference in mortality risk between HD and PD. 28, 42 This suggests patients should be able to start on either modalities based on their clinical and psychosocial needs when the time is right.
The effects of hypoalbuminemia on mortality have been inconsistent in the literature [46] [47] [48] because of reasons such as the presence of inflammation (duration and magnitude) and duration and the severity of hypoalbuminemia. The present study indicated that s-albumin levels were an independent predicator of mortality. This result was consistent with the findings of a number of studies, 23, 47, 49, 50 but differed from others. 28, 48, 51 In the latter studies, the predictive effect of s-albumin was ameliorated after adjusting for CRP, and this may be a limitation of our study because CRP was not routinely measured. Therefore, the independent predictive effect of s-albumin as solely nutritional could not be concluded. However, we did consider for other study variables, including the known associates of inflammation such as history of AKI, surgery (PD catheter insertion), obesity, and other comorbidities. Thus, it is reasonable to speculate the strong role of poor nutrition or type I malnutrition caused by a reduced protein and energy intake 2 plays in the predictive effect of s-albumin levels in our study, similar to other reports in the literature. 19, 29 Similar to previous findings, the SGA rating of malnutrition was found to be an independent predictor of mortality. 28, 49, 52 A sustained reduction of dietary intake is a major determinant of SGA rating, and as we considered sustained intakes of protein and energy of less than 80% of requirements as inadequate, it was reasonable to deduce that the predictive effect of low s-albumin levels constituted a significant nutrition component. It is possible that both type I and type II malnutrition coexist with nutritional and inflammatory factors compounding the effects on each other, and their significance cannot be mutually exclusive. We did not examine the effect of the individual components of SGA on survival, but it is known that these individual components reflect long-term changes and are highly predictive of mortality and morbidities, such as unintentional weight loss, 19, 53 reduced dietary intake, 50, 54, 55 poor appetite, 26, 56 and muscle wasting. 57 Our study supports the use of SGA score at the start of dialysis as a powerful independent predictor of survival, as previously reported by other researchers. 28, 49, 52 In contrast to the literature, 28 ,49,50 diabetes was not observed to be associated with higher mortality risk in our study. This may be explained by a higher proportion of our patients with diabetes being well nourished, possibly counteracting the effects of the uremic wasting on mortality over time. Our results were similar to those of the Dialysis Outcomes and Practice Patterns Study (DOPPS) 58 which reported diabetic patients had significantly lower odds of cachectic appearance than nondiabetic patients. Cardiovascular disease was found to be an independent predictor of mortality in several studies. 28, 49, 59 We found CAD to be significant in the unadjusted analyses, but the significance disappeared in the adjusted analyses (HR, 1.45; 95% CI, 0.94 to 2.19; P 5 .10). This can possibly be explained by the unknown duration and severity of cardiovascular conditions in our cohort. Also, our patients were much older (mean age, 65.3 6 13.6 years compared with 50 to 56 years in these studies), and the age factors may explain some of the variation in our findings. Other reasons could be the varied observational periods or the heterogeneity of uremia-related nutritional effects before starting dialysis in previous studies. Such reasons include unplanned initiation of dialysis because of unforeseen events (e.g., AKI caused by infections and surgical complications), duration of malnutrition, and previous transplantation. It is not clear whether dialysis was initiated for the same reasons in all patients in reported studies.
The obesity paradox 32, 33, 60, 61 has created much debate in the renal community regarding the protective effect of obesity in ESKD patients. A recent systematic review 62 of the relationship between BMI and mortality supported the inverse association between BMI and all-cause mortality in adult (HD) patients, especially in elderly patients. In other studies, 50, 63, 64 it has been argued that when body composition was also considered, the possible protective effect of high BMI is limited to subjects with normal and high muscle mass only. Similarly to previous findings, 31, 65 our study revealed being overweight or obese was not found to have any protective effects, and when combining with malnutrition scores, it was associated with the worst outcome. Our findings echoed the high mortality risk found in those with obese sarcopenia. 66 In addition, the combined effects SGA A and BMI ,26 kg/m 2 were found to have the best survival advantage. Again, higher BMI did not show protective effects with either low or normal levels of s-albumin. Most importantly, being well nourished (SGA A) was found to be associated with lower mortality risk irrespective of the levels of s-albumin and BMI. Our study highlighted the usefulness of the combined effects of nutritional parameters in predicting outcomes.
There are limitations to our study. The main ones are the lack of measurement of inflammatory biomarkers (CRP), small sample size, and unknown duration and severity of lifestyle factors such as smoking history and comorbidities (e.g., CAD). We also did not measure the effect of nutrition interventions before and after dialysis initiation. Patients may respond to nutritional management differently depending on the type, severity, and duration of their nutritional issues, and the degree of exposure to intervention. Our study points to the need for timely access to structured nutritional care to prevent and manage nutritional abnormalities well before dialysis is required, and if it is required, to help maintain nutrition status on the conservative management pathway.
The strength of this study is the long follow-up time in a well-defined cohort of patients experiencing relatively homogeneous nutritional effects before dialysis started. It is a good example of how informative research can be conducted within the practice of renal care.
Conclusions
In the study reported here, a high prevalence of malnutrition among patients with ESKD at the initiation of dialysis was observed. During a 10-year period, advanced age (.65 years), reduced s-albumin levels, presence of PVD, and malnutrition scores were found to independently predict mortality. Other studied factors, such as gender, dialysis modality, GFR level at which dialysis was initiated, BMI, positive smoking history, and presence of all other comorbidities, were not found to be associated with higher mortality risk. A high BMI was not associated with any survival advantage, and when combined with the presence of malnutrition, it was associated with the highest mortality risk. The combined effects of these simple readily available nutritional parameters were effective in predicting mortality independently and are highly informative for practice management and evaluation.
Practical Application
Malnutrition scored by SGA (B and C) at the start of dialysis was associated with high mortality risk irrespective of the BMI and s-albumin levels. Being overweight or obese did not show any protective effect and was associated with the worst outcome with the presence of malnutrition. These findings suggest nutrition intervention to optimize nutritional status should be considered in patients with ESKD well before dialysis is required.
